DE60108398D1 - Kristallin-therapeutisches mittel - Google Patents

Kristallin-therapeutisches mittel

Info

Publication number
DE60108398D1
DE60108398D1 DE60108398T DE60108398T DE60108398D1 DE 60108398 D1 DE60108398 D1 DE 60108398D1 DE 60108398 T DE60108398 T DE 60108398T DE 60108398 T DE60108398 T DE 60108398T DE 60108398 D1 DE60108398 D1 DE 60108398D1
Authority
DE
Germany
Prior art keywords
therapeutic agent
crystalline therapeutic
crystalline
agent
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60108398T
Other languages
English (en)
Other versions
DE60108398T2 (de
Inventor
James Harris
Anthony Storey
Shaw Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018656A external-priority patent/GB0018656D0/en
Priority claimed from GB0106464A external-priority patent/GB0106464D0/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE60108398D1 publication Critical patent/DE60108398D1/de
Application granted granted Critical
Publication of DE60108398T2 publication Critical patent/DE60108398T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DE60108398T 2000-07-28 2001-07-18 Kristallin-therapeutisches mittel Expired - Fee Related DE60108398T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0018656 2000-07-28
GB0018656A GB0018656D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
GB0106464 2001-03-15
GB0106464A GB0106464D0 (en) 2001-03-15 2001-03-15 Crystalline therapeutic agent
PCT/IB2001/001280 WO2002010171A1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent

Publications (2)

Publication Number Publication Date
DE60108398D1 true DE60108398D1 (de) 2005-02-17
DE60108398T2 DE60108398T2 (de) 2005-12-22

Family

ID=26244756

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60108398T Expired - Fee Related DE60108398T2 (de) 2000-07-28 2001-07-18 Kristallin-therapeutisches mittel

Country Status (46)

Country Link
EP (1) EP1305314B1 (de)
JP (1) JP2004505087A (de)
KR (1) KR100457937B1 (de)
CN (1) CN1207297C (de)
AP (1) AP1400A (de)
AR (1) AR032628A1 (de)
AT (1) ATE286901T1 (de)
AU (2) AU7269001A (de)
BG (1) BG107266A (de)
BR (1) BR0112734A (de)
CA (1) CA2417264C (de)
CZ (1) CZ2003126A3 (de)
DE (1) DE60108398T2 (de)
DO (1) DOP2001000217A (de)
DZ (1) DZ3364A1 (de)
EA (1) EA004681B1 (de)
EC (1) ECSP034454A (de)
EE (1) EE200300045A (de)
ES (1) ES2231521T3 (de)
GE (1) GEP20053494B (de)
HK (1) HK1055954A1 (de)
HR (1) HRP20030061A2 (de)
HU (1) HUP0302982A3 (de)
IL (1) IL153226A0 (de)
IN (1) IN2002MU01649A (de)
IS (1) IS6626A (de)
MA (1) MA26931A1 (de)
MX (1) MX233602B (de)
MY (1) MY117831A (de)
NO (1) NO324220B1 (de)
NZ (1) NZ523226A (de)
OA (1) OA12337A (de)
PA (1) PA8523501A1 (de)
PE (1) PE20020277A1 (de)
PH (1) PH12001001922B1 (de)
PL (1) PL365133A1 (de)
PT (1) PT1305314E (de)
SK (1) SK572003A3 (de)
SV (1) SV2001000570A (de)
TN (1) TNSN01112A1 (de)
TW (1) TWI285643B (de)
UA (1) UA72631C2 (de)
UY (1) UY26854A1 (de)
WO (1) WO2002010171A1 (de)
YU (1) YU4703A (de)
ZA (1) ZA200301457B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
JP4015176B2 (ja) 2003-04-29 2007-11-28 ファイザー・インク 高血圧症の治療に有用な５，７−ジアミノピラゾロ４，３−ジピリミジン類
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
DK1742950T3 (da) 2004-04-07 2009-03-16 Pfizer Ltd Pyrazolo-[4,3-D]-pyrimidiner
BRPI0609225A2 (pt) 2005-05-12 2010-03-09 Pfizer formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n-etil-n-metilamino)-7-(4-metilpiridi n-2-il-amino)-1h-pirazolo[4,3-d]pirimidina-3-carbonil] metanossulfonamida, composição farmacêutica compreendendo as mesmas e uso das mesmas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE247117T1 (de) * 1998-04-20 2003-08-15 Pfizer Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen
TWI265925B (en) * 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them

Also Published As

Publication number Publication date
PA8523501A1 (es) 2002-10-24
ECSP034454A (es) 2003-03-10
AU7269001A (en) 2002-02-13
NZ523226A (en) 2003-07-25
UY26854A1 (es) 2002-02-28
EE200300045A (et) 2004-12-15
HRP20030061A2 (en) 2003-04-30
KR20030016430A (ko) 2003-02-26
HUP0302982A3 (en) 2005-01-28
AP1400A (en) 2005-04-28
MA26931A1 (fr) 2004-12-20
DOP2001000217A (es) 2002-10-30
AU2001272690B2 (en) 2005-12-08
ES2231521T3 (es) 2005-05-16
EA004681B1 (ru) 2004-06-24
NO324220B1 (no) 2007-09-10
WO2002010171A1 (en) 2002-02-07
CA2417264A1 (en) 2002-02-07
BG107266A (bg) 2003-07-31
SV2001000570A (es) 2002-09-03
HUP0302982A2 (hu) 2003-12-29
MX233602B (es) 2006-01-10
MXPA03000856A (es) 2003-06-06
YU4703A (sh) 2006-01-16
EP1305314A1 (de) 2003-05-02
BR0112734A (pt) 2004-08-10
HK1055954A1 (en) 2004-01-30
AP2001002234A0 (en) 2001-09-30
SK572003A3 (en) 2004-05-04
JP2004505087A (ja) 2004-02-19
TNSN01112A1 (fr) 2005-11-10
PE20020277A1 (es) 2002-05-11
OA12337A (en) 2006-05-15
CN1444585A (zh) 2003-09-24
GEP20053494B (en) 2005-04-25
ATE286901T1 (de) 2005-01-15
UA72631C2 (uk) 2005-03-15
CN1207297C (zh) 2005-06-22
IN2002MU01649A (de) 2004-12-11
CZ2003126A3 (cs) 2004-02-18
DE60108398T2 (de) 2005-12-22
AR032628A1 (es) 2003-11-19
ZA200301457B (en) 2004-04-28
PT1305314E (pt) 2005-04-29
NO20030416D0 (no) 2003-01-27
DZ3364A1 (fr) 2002-02-07
IL153226A0 (en) 2003-07-06
PH12001001922B1 (en) 2006-11-21
PL365133A1 (en) 2004-12-27
IS6626A (is) 2002-11-18
KR100457937B1 (ko) 2004-11-20
CA2417264C (en) 2007-06-12
TWI285643B (en) 2007-08-21
NO20030416L (no) 2003-02-05
EP1305314B1 (de) 2005-01-12
MY117831A (en) 2004-08-30
EA200300079A1 (ru) 2003-06-26

Similar Documents

Publication Publication Date Title
DK1335678T3 (da) Oralt behandlingssystem
ATE391531T1 (de) Schweisshemmende mittel
DE60106275D1 (de) Dermatologisches mittel
DK1637127T3 (da) Terapeutisk mikroskum
DE69924365D1 (de) Massagegerät
DK1199054T3 (da) Væskefrakturhånddel
NO20025580D0 (no) Medisinsk anordning
DK1265511T3 (da) Tandbørste
NO20014490D0 (no) Medisinske blandinger
NO20022692D0 (no) Terapeutiske midler
DE60007530D1 (de) Oral wirksame androgene
NO20032122D0 (no) Forbedret behandling
EE200200568A (et) Ravis kasutatavad difenüüleetriühendid
DE60112774D1 (de) Reibungsarme zahnbürste
DE60009451D1 (de) Massagegerät
ID30397A (id) Larutan oral prukaloprida
DE60023003D1 (de) Haarbehandlungsmittel
ATE286901T1 (de) Kristallin-therapeutisches mittel
DE60220799D1 (de) Hypoglykämisches mittel
NO20016301D0 (no) Terapeutiske midler
DE60136966D1 (de) Pflanzenstärkendes mittel
DK1305314T3 (da) Krystallinsk terapeutisk middel
ATA7922000A (de) Elektromedizinisches gerät
FR2816398B3 (fr) Fronde perfectionnee
SE0003368D0 (sv) Therapeutic compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee